搜尋
Portage Biotech Inc
PRTG添加自選
6.810USD
0.0000.00%
收盤 07/02, 16:00（美東）報價延遲15分鐘
11.26M總市值
虧損本益比TTM
關於 Portage Biotech Inc 公司
Portage Biotech Inc. 是一家臨牀階段的免疫腫瘤學公司。該公司致力於推進治療方法，以改善癌症患者的長期治療反應和生活質量。該公司利用技術與生物機制相結合，能夠確定臨牀治療方法和產品開發策略，從而加速這些藥物通過轉化渠道。該公司的產品組合由四個平臺組成，主要項目包括不變的自然殺傷 T 細胞 (iNKT) 接合劑和一套針對腺苷途徑的治療方法。在這四個平臺中，該公司有九個候選產品，其中五個處於臨牀前階段，四個處於臨牀階段。該公司的產品組合還包括小分子腺苷抑制劑，例如 PORT-6、PORT-7、PORT-8 和 PORT-9，它們代表針對腺苷途徑。
Portage Biotech Inc簡介
公司代碼PRTG
公司名稱Portage Biotech Inc
上市日期Oct 28, 2013
CEOMr. Alexander (Alex) Pickett
員工數量3
證券類型Ordinary Share
年結日Oct 28
公司地址Clarence Thomas Building
城市TORTOLA
上市交易所NASDAQ Capital Market Consolidated
國家Virgin Islands; British
郵編VG1110
電話4167377600
網址https://portagebiotech.com/
公司代碼PRTG
上市日期Oct 28, 2013
CEOMr. Alexander (Alex) Pickett
Portage Biotech Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Gregory Hugh (Greg) Bailey, M.D.
Dr. Gregory Hugh (Greg) Bailey, M.D.
Lead Independent Director
Lead Independent Director
467.80K
-0.00%
Mr. James (Jim) Mellon
Mr. James (Jim) Mellon
Independent Director
Independent Director
239.54K
-0.01%
Mr. Steven Michael (Steve) Mintz
Mr. Steven Michael (Steve) Mintz
Independent Director
Independent Director
7.00K
+2.19%
Mr. Robert Kramer, Ph.D.
Mr. Robert Kramer, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.04K
-0.56%
Mr. Alexander (Alex) Pickett
Mr. Alexander (Alex) Pickett
Chief Executive Officer, Director
Chief Executive Officer, Director
38.00
--
Ms. Andrea Park
Ms. Andrea Park
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Ian B. Walters, M.D.
Dr. Ian B. Walters, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Andrew D. Hudders
Mr. Andrew D. Hudders
Investor Relations
Investor Relations
--
--
Dr. Jean-Christophe Renondin, M.D.
Dr. Jean-Christophe Renondin, M.D.
Independent Director
Independent Director
--
--
Mr. Justin Fairchild
Mr. Justin Fairchild
Vice President - Development
Vice President - Development
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Gregory Hugh (Greg) Bailey, M.D.
Dr. Gregory Hugh (Greg) Bailey, M.D.
Lead Independent Director
Lead Independent Director
467.80K
-0.00%
Mr. James (Jim) Mellon
Mr. James (Jim) Mellon
Independent Director
Independent Director
239.54K
-0.01%
Mr. Steven Michael (Steve) Mintz
Mr. Steven Michael (Steve) Mintz
Independent Director
Independent Director
7.00K
+2.19%
Mr. Robert Kramer, Ph.D.
Mr. Robert Kramer, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.04K
-0.56%
Mr. Alexander (Alex) Pickett
Mr. Alexander (Alex) Pickett
Chief Executive Officer, Director
Chief Executive Officer, Director
38.00
--
Ms. Andrea Park
Ms. Andrea Park
Chief Financial Officer
Chief Financial Officer
--
--
常見問題
Portage Biotech Inc的前五大股東是誰？
Portage Biotech Inc的前五大股東如下：Dr. Gregory Hugh (Greg) Bailey, M.D.
有多少機構持有Portage Biotech Inc(PRTG)的股份？
截至2026Q1，共有48家機構持有Portage Biotech Inc的股份，合計持有的股份價值約為928.66K，占公司總股份的3.96% 。與2025Q4相比，機構持股有所增加，增幅為644865.00。